臨床試験管理の世界市場2021-2028

◆英語タイトル:GLOBAL CLINICAL TRIAL MANAGEMENT MARKET FORECAST 2021-2028
◆商品コード:INK21JU011
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2021年5月3日
◆ページ数:204
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD4,500 ⇒換算¥495,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートは臨床試験管理の世界市場について調査・分析し、調査範囲/手法、エグゼクティブサマリー、市場動向、主要分析、エンドユーザー別(製薬・バイオテクノロジー企業、臨床研究機関、医療機関)分析、製品種類別(企業ベースCTM、サイトベースCTM)分析、展開別(Webベース展開、オンプレミス展開、クラウドベース展開)分析、構成要素別(ソフトウェア、ハードウェア、サービス)分析、地域別分析、競争状況などを掲載したものです。
・調査範囲/手法
・エグゼクティブサマリー
・市場動向
・主要分析
・臨床試験管理の世界市場規模:エンドユーザー別(製薬・バイオテクノロジー企業、臨床研究機関、医療機関)
・臨床試験管理の世界市場規模:製品種類別(企業ベースCTM、サイトベースCTM)
・臨床試験管理の世界市場規模:展開別(Webベース展開、オンプレミス展開、クラウドベース展開)
・臨床試験管理の世界市場規模:構成要素別(ソフトウェア、ハードウェア、サービス)
・地域別分析
・競争状況
【レポートの概要】

KEY FINDINGS
The global clinical trial management market is set to project a CAGR of 11.77% during the forecast period, 2021-2028. The growing number of clinical trials, research & development, rising chronic disease incidences, CTM software benefits, and research & development are significant growth drivers.
MARKET INSIGHTS
Clinical trial management systems include various components that comprise services, hardware, and software. It helps in maintaining the complex data obtained from clinical trials. Clinical trials are on the rise globally, attributed to technological advancements and the growing demand for advanced drugs with fewer side effects. The discovery of new treatments is propelled by rapid innovations in data management, biotechnology, and artificial intelligence. With every new drug, treatment, and device needing to undergo clinical trial, the volume of trials continues to rise.
Moreover, medicine is changing at a fast-paced pace. There is an increasing demand for services and software to manage the piling data from the rising clinical trials. Such factors are projected to drive market growth. However, the implantation costs, security concerns, and the lack of skilled healthcare professionals hinder the market growth.
REGIONAL INSIGHTS
The global clinical trial management market growth evaluation includes the analysis of Asia-Pacific, Europe, North America, and Rest of World. North America is estimated to harbor the largest revenue share. At the same time, Asia-Pacific is set to record the highest CAGR by 2028. The market prospects of Asia-Pacific are attributed to the increasing clinical trial management product awareness and dense population base.
COMPETITIVE INSIGHTS
The market has an increasing number of market players, along with a considerable scope of innovation. Bio-Optronics Inc, Medidata Solutions Inc, Arisglobal LLC, Bioclinica Inc, etc., are among the leading companies in the market.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. PARENT MARKET ANALYSIS – HEALTHCARE
3.2. MARKET SCOPE
3.3. KEY DRIVERS
3.3.1. OUTSOURCING OF CLINICAL TRIALS
3.3.2. GROWTH IN THE NUMBER OF CLINICAL TRIALS
3.3.3. AWARENESS REGARDING THE BENEFITS OF CTM SOFTWARE
3.3.4. INCIDENCES OF CHRONIC DISEASES
3.3.5. RESEARCH & DEVELOPMENT
3.4. KEY RESTRAINTS
3.4.1. SCARCITY OF SKILLED HEALTHCARE PROFESSIONALS
3.4.2. COST OF IMPLEMENTATION
3.4.3. SECURITY CONCERNS
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON CLINICAL TRIAL MANAGEMENT MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. THREAT OF SUBSTITUTION
4.3.4. THREAT OF NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
5. MARKET BY END-USER
5.1. PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
5.2. CLINICAL RESEARCH ORGANIZATIONS
5.3. HEALTHCARE PROVIDERS
6. MARKET BY PRODUCT TYPE
6.1. ENTERPRISE-BASED CTM
6.2. SITE-BASED CTM
7. MARKET BY DEPLOYMENT MODEL
7.1. WEB-BASED DEPLOYMENT
7.2. ON-PREMISE DEPLOYMENT
7.3. CLOUD-BASED DEPLOYMENT
8. MARKET BY COMPONENT
8.1. SOFTWARE
8.2. HARDWARE
8.3. SERVICES
9. GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1. MARKET SIZE & ESTIMATES
9.1.2. KEY GROWTH ENABLERS
9.1.3. KEY CHALLENGES
9.1.4. KEY PLAYERS
9.1.5. COUNTRY ANALYSIS
9.1.5.1. UNITED STATES
9.1.5.2. CANADA
9.2. EUROPE
9.2.1. MARKET SIZE & ESTIMATES
9.2.2. KEY GROWTH ENABLERS
9.2.3. KEY CHALLENGES
9.2.4. KEY PLAYERS
9.2.5. COUNTRY ANALYSIS
9.2.5.1. UNITED KINGDOM
9.2.5.2. GERMANY
9.2.5.3. FRANCE
9.2.5.4. ITALY
9.2.5.5. RUSSIA
9.2.5.6. BELGIUM
9.2.5.7. POLAND
9.2.5.8. REST OF EUROPE
9.3. ASIA-PACIFIC
9.3.1. MARKET SIZE & ESTIMATES
9.3.2. KEY GROWTH ENABLERS
9.3.3. KEY CHALLENGES
9.3.4. KEY PLAYERS
9.3.5. COUNTRY ANALYSIS
9.3.5.1. CHINA
9.3.5.2. JAPAN
9.3.5.3. INDIA
9.3.5.4. SOUTH KOREA
9.3.5.5. INDONESIA
9.3.5.6. THAILAND
9.3.5.7. VIETNAM
9.3.5.8. AUSTRALIA & NEW ZEALAND
9.3.5.9. REST OF ASIA-PACIFIC
9.4. REST OF WORLD
9.4.1. MARKET SIZE & ESTIMATES
9.4.2. KEY GROWTH ENABLERS
9.4.3. KEY CHALLENGES
9.4.4. KEY PLAYERS
9.4.5. REGION ANALYSIS
9.4.5.1. LATIN AMERICA
9.4.5.2. MIDDLE EAST AND AFRICA
10. COMPETITIVE LANDSCAPE
10.1. KEY STRATEGIC DEVELOPMENTS
10.1.1. MERGERS & ACQUISITIONS
10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
10.1.3. PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
10.2. COMPANY PROFILES
10.2.1. ADVARRA (FORTE RESEARCH SYSTEMS INC)
10.2.2. ARISGLOBAL LLC
10.2.3. BIOCLINICA INC
10.2.4. BIO-OPTRONICS INC
10.2.5. IBM CORPORATION
10.2.6. MEDIDATA SOLUTIONS INC
10.2.7. MEDNET SOLUTIONS INC
10.2.8. ORACLE CORPORATION
10.2.9. PAREXEL INTERNATIONAL CORPORATION
10.2.10. VEEVA SYSTEMS INC

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - CLINICAL TRIAL MANAGEMENT
TABLE 2: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 4: GLOBAL PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: GLOBAL PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: GLOBAL CLINICAL RESEARCH ORGANIZATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: GLOBAL CLINICAL RESEARCH ORGANIZATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: GLOBAL HEALTHCARE PROVIDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: GLOBAL HEALTHCARE PROVIDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 12: GLOBAL ENTERPRISE-BASED CTM MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 13: GLOBAL ENTERPRISE-BASED CTM MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 14: GLOBAL SITE-BASED CTM MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 15: GLOBAL SITE-BASED CTM MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 16: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODEL, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 17: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODEL, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 18: GLOBAL WEB-BASED DEPLOYMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 19: GLOBAL WEB-BASED DEPLOYMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 20: GLOBAL ON-PREMISE DEPLOYMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 21: GLOBAL ON-PREMISE DEPLOYMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 22: GLOBAL CLOUD-BASED DEPLOYMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 23: GLOBAL CLOUD-BASED DEPLOYMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 24: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 25: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 26: GLOBAL SOFTWARE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 27: GLOBAL SOFTWARE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 28: GLOBAL HARDWARE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 29: GLOBAL HARDWARE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 30: GLOBAL SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 31: GLOBAL SERVICES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 32: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 33: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY GEOGRAPHY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 34: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 35: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 36: KEY PLAYERS OPERATING IN NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET
TABLE 37: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 38: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 39: KEY PLAYERS OPERATING IN EUROPE CLINICAL TRIAL MANAGEMENT MARKET
TABLE 40: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 41: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 42: KEY PLAYERS OPERATING IN ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET
TABLE 43: REST OF WORLD CLINICAL TRIAL MANAGEMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 44: REST OF WORLD CLINICAL TRIAL MANAGEMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 45: KEY PLAYERS OPERATING IN THE REST OF WORLD CLINICAL TRIAL MANAGEMENT MARKET
TABLE 46: LIST OF MERGERS & ACQUISITIONS
TABLE 47: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 48: LIST OF PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS


LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020
FIGURE 6: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 7: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY CLINICAL RESEARCH ORGANIZATIONS, 2021-2028 (IN $ MILLION)
FIGURE 8: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY HEALTHCARE PROVIDERS, 2021-2028 (IN $ MILLION)
FIGURE 9: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2020
FIGURE 10: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY ENTERPRISE-BASED CTM, 2021-2028 (IN $ MILLION)
FIGURE 11: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY SITE-BASED CTM, 2021-2028 (IN $ MILLION)
FIGURE 12: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY DEPLOYMENT MODEL, IN 2020
FIGURE 13: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY WEB-BASED DEPLOYMENT, 2021-2028 (IN $ MILLION)
FIGURE 14: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY ON-PREMISE DEPLOYMENT, 2021-2028 (IN $ MILLION)
FIGURE 15: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY CLOUD-BASED DEPLOYMENT, 2021-2028 (IN $ MILLION)
FIGURE 16: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY COMPONENT, IN 2020
FIGURE 17: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY SOFTWARE, 2021-2028 (IN $ MILLION)
FIGURE 18: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY HARDWARE, 2021-2028 (IN $ MILLION)
FIGURE 19: GLOBAL CLINICAL TRIAL MANAGEMENT MARKET, BY SERVICES, 2021-2028 (IN $ MILLION)
FIGURE 20: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 21: UNITED STATES CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 22: CANADA CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 23: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 24: UNITED KINGDOM CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 25: GERMANY CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 26: FRANCE CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 27: ITALY CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 28: RUSSIA CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 29: BELGIUM CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 30: POLAND CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 31: REST OF EUROPE CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 32: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 33: CHINA CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 34: JAPAN CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 35: INDIA CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 36: SOUTH KOREA CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 37: INDONESIA CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 38: THAILAND CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 39: VIETNAM CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 40: AUSTRALIA & NEW ZEALAND CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 41: REST OF ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 42: REST OF WORLD CLINICAL TRIAL MANAGEMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 43: LATIN AMERICA CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 44: MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[臨床試験管理の世界市場2021-2028]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆